Circulating T cells fuel anti-PD-1 and lenvatinib efficacy.
Saved in:
| Title: | Circulating T cells fuel anti-PD-1 and lenvatinib efficacy. |
|---|---|
| Authors: | Matulich PJ; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA., Burger ML; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. Electronic address: burgerm@ohsu.edu. |
| Source: | Cancer cell [Cancer Cell] 2025 Feb 10; Vol. 43 (2), pp. 173-175. Date of Electronic Publication: 2025 Jan 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1878-3686 |
|---|---|
| DOI: | 10.1016/j.ccell.2024.12.003 |
